Vetter Pharma Fertigung GmbH & Co. KG

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40015033

Informations générales

Localisation

Germany

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

17/07/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%
2015 (année de référence)2034
Description complète des objectifs

Near-Term Targets: Vetter Pharma-Fertigung GmbH & Co. KG commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2021 base year. Vetter Pharma-Fertigung GmbH & Co. KG also commits that 80% of its suppliers by spend, covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2029.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

529900IEX1C2YL18RC40

Source : Science Based Targets initiative | Données publiques